Atsuko Koyama

Osaka, 5898511, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain.

Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain.

Journal: Molecular and clinical oncology
Published: September 03, 2024

Effects of laughter on focus and stress in middle-aged adults: a single-blind, randomized controlled trial.

Effects of laughter on focus and stress in middle-aged adults: a single-blind, randomized controlled trial.

Journal: BMC complementary medicine and therapies
Published: June 18, 2024

Efficacy of Comedy on Health-Related Quality of Life and Oxidative Stress in Cancer Survivors.

Efficacy of Comedy on Health-Related Quality of Life and Oxidative Stress in Cancer Survivors.

Journal: Cureus
Published: July 31, 2023

Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.

Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.

Journal: Oncology letters
Published: March 16, 2023

Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).

Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).

Journal: The oncologist
Published: June 22, 2022

Analysis of Various Factors Associated With Opioid Dose Escalation in Patients With Cancer Pain.

Analysis of Various Factors Associated With Opioid Dose Escalation in Patients With Cancer Pain.

Journal: Cureus
Published: May 23, 2022

Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol.

Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol.

Journal: BMJ open
Published: February 08, 2022

Identifying the Needs Based on the Patients' Performance Status for Palliative Care Team: An Observational Study.

Identifying the Needs Based on the Patients' Performance Status for Palliative Care Team: An Observational Study.

Journal: Indian journal of palliative care
Published: July 09, 2021

Fentanyl Infusion Is Effective in the Treatment of Dyspnea in End-Stage Heart Failure With Renal Failure: A Case Report.

Fentanyl Infusion Is Effective in the Treatment of Dyspnea in End-Stage Heart Failure With Renal Failure: A Case Report.

Journal: Cureus
Published: February 19, 2021

Effective Therapy Against Severe Anxiety Caused by Cancer: A Case Report and Review of the Literature.

Effective Therapy Against Severe Anxiety Caused by Cancer: A Case Report and Review of the Literature.

Journal: Cureus
Published: July 07, 2020

The current clinical use of adjuvant analgesics for refractory cancer pain in Japan: a nationwide cross-sectional survey.

The current clinical use of adjuvant analgesics for refractory cancer pain in Japan: a nationwide cross-sectional survey.

Journal: Japanese journal of clinical oncology
Published: June 02, 2020

Between-group difference in mean values or changes in pain intensity? Evaluating the distribution of change from baseline in a neuropathic cancer pain clinical trial.

Between-group difference in mean values or changes in pain intensity? Evaluating the distribution of change from baseline in a neuropathic cancer pain clinical trial.

Journal: Annals of palliative medicine
Published: April 27, 2020
Showing 1-12 of 35

Last Updated: 09/26/2026